Phase 1 Adenoid Cystic Carcinoma Clinical Trials
4 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
Adenoid Cystic CarcinomaMetastatic Adenoid Cystic CarcinomaRecurrent Adenoid Cystic Carcinoma
Remix Therapeutics100 enrolled8 locationsNCT06118086
Recruiting
Phase 1Phase 2
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck CarcinomaLung CancerAdenoid Cystic Carcinoma
VM Oncology, LLC242 enrolled15 locationsNCT03556228
Recruiting
Phase 1
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)
Adenoid Cystic Carcinoma
Rgenta Therapeutics Inc105 enrolled10 locationsNCT06462183
Recruiting
Phase 1Phase 2
CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC
Adenoid Cystic CarcinomaMetastatic Adenoid Cystic CarcinomaRecurrent Adenoid Cystic Carcinoma
Glenn J. Hanna32 enrolled1 locationNCT05774899